Article Correctness Is Author's Responsibility: Epidiolex Now Available to Treat Seizures Associated With LGS, Dravet Syndrome

The article below may contain offensive and/or incorrect content.

The Food and Drug Administration (FDA) approved the treatment in June 2018, making it the first prescription pharmaceutical formulation of highly-purified, plant-derived cannabidiol, as well as the first treatment indicated for patients with Dravet syndrome.